Analyst Ratings for Janux Therapeutics (JANX)
JANX Rating Summary
JANX Price Target Summary
- Highest: $60.00 (Cantor Fitzgerald)
- Lowest: $12.00 (Clear Street)
- Average: $31.85
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.85 (+95.9%)
* Over Last 12-Mos
Rating Score: 7.4 / 10
Percentile Rank: 77%
Avg. $ Target:
$31.85 (+95.9%)
* Over Last 12-Mos
Rating Score: 7.4 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Barclays | Etzer Darout | Downgrade | Underweight (Overweight) |
14.00 (29.00) |
15.19 (16.26) |
7.04% | Details |
| 4/15/2026 | UBS | David Dai | Downgrade | Neutral (Buy) |
15.00 (57.00) |
14.90 (16.26) |
9.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
